Relx PLC
F:RDED
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Relx PLC
F:RDED
|
UK |
|
R
|
Relx PLC
DUS:RDEB
|
UK |
|
K
|
Kforce Inc
F:ROF
|
US |
|
B
|
Baloise Holding AG
LSE:0QQ3
|
CH |
|
E
|
Expeditors International of Washington Inc
XMUN:EW1
|
US |
|
H
|
Hovnanian Enterprises Inc
OTC:HOVVB
|
US |
|
O
|
ONWARD Medical NV
F:63E
|
NL |
|
S
|
Supernus Pharmaceuticals Inc
F:S49
|
US |
|
Aegon NV
F:AEND
|
NL |
|
H
|
Henry Schein Inc
F:HS2
|
US |
|
F
|
Falabella SA
SGO:FALABELLA
|
CL |
|
Lenovo Group Ltd
OTC:LNVGY
|
CN |
Cash Flow Statement
Cash Flow Statement
Relx PLC
| Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|
| Operating Cash Flow | ||||
| Net Income |
2 861
|
2 920
|
3 027
|
|
| Depreciation & Amortization |
783
|
773
|
752
|
|
| Stock-Based Compensation |
66
|
66
|
63
|
|
| Other Non-Cash Items |
23
|
22
|
19
|
|
| Cash Taxes Paid |
662
|
636
|
638
|
|
| Cash Interest Paid |
257
|
275
|
274
|
|
| Change in Working Capital |
(1 059)
|
(952)
|
(962)
|
|
| Cash from Operating Activities |
2 608
N/A
|
2 763
+6%
|
2 836
+3%
|
|
| Investing Cash Flow | ||||
| Capital Expenditures |
(484)
|
(506)
|
(525)
|
|
| Other Items |
(91)
|
(337)
|
(245)
|
|
| Cash from Investing Activities |
(575)
N/A
|
(843)
-47%
|
(770)
+9%
|
|
| Financing Cash Flow | ||||
| Net Issuance of Common Stock |
(1 028)
|
(1 335)
|
(1 534)
|
|
| Net Issuance of Debt |
94
|
683
|
698
|
|
| Cash Paid for Dividends |
(1 121)
|
(1 163)
|
(1 181)
|
|
| Other |
(10)
|
(31)
|
(34)
|
|
| Cash from Financing Activities |
(2 065)
N/A
|
(1 846)
+11%
|
(2 051)
-11%
|
|
| Change in Cash | ||||
| Effect of Foreign Exchange Rates |
(4)
|
(3)
|
(3)
|
|
| Net Change in Cash |
(36)
N/A
|
71
N/A
|
12
-83%
|
|
| Free Cash Flow | ||||
| Free Cash Flow |
2 124
N/A
|
2 257
+6%
|
2 311
+2%
|
|